Diversify Advisory Services, LLC Halozyme Therapeutics, Inc. Transaction History
Diversify Advisory Services, LLC
- $1.82 Trillion
- Q2 2024
A detailed history of Diversify Advisory Services, LLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Diversify Advisory Services, LLC holds 4,913 shares of HALO stock, worth $265,498. This represents 0.01% of its overall portfolio holdings.
Number of Shares
4,913
Previous 8,331
41.03%
Holding current value
$265,498
Previous $344 Million
24.53%
% of portfolio
0.01%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding HALO
# of Institutions
450Shares Held
123MCall Options Held
216KPut Options Held
129K-
Black Rock Inc. New York, NY18.2MShares$986 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA13MShares$705 Million0.01% of portfolio
-
State Street Corp Boston, MA6.49MShares$351 Million0.01% of portfolio
-
Snyder Capital Management L P San Francisco, CA4.12MShares$222 Million3.73% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI3.79MShares$205 Million0.24% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $7.53B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...